Home > Insider Trading > Filing (0001367644-21-000004)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367644	Emergent Biosolutions Inc.	EBS	Pharmaceutical Preparations (2834)	141902018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380956	Robert Kramer	400 Professional Dr, Suite 400 Gaithersburg MD 20879	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-01-15	19,026	$25.62	158,236	No	4	M	Direct
Common Stock	Disposition	2021-01-15	19,026	$106.01	139,210	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Options (Right to Buy)	Disposition	2021-01-15	19,026	$0.00	19,026	$25.62

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-03-10	No	4	M	Direct

Footnotes

Consists of an option granted on 03/11/2014 under the company's stock incentive plan as amended and restated.
All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
The number of derivative securities beneficially owned was adjusted to account for a change in previously reported PSUs. 8,163 PSUs were previously reported, of which only 5,169 vested on February 11, 2020.
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.52 to $107.79.